Skip to main content
. Author manuscript; available in PMC: 2021 Dec 16.
Published in final edited form as: ACS Bio Med Chem Au. 2021 Sep 10;1(1):31–43. doi: 10.1021/acsbiomedchemau.1c00021

Figure 3.

Figure 3.

(A) Schematic scheme of the OVA model system. (B) Readout of IL-2 release from treatment of P338D1 macrophages with various controls and B13G-AuNPs, followed by incubation with OVA-specific T-cell clone Do-11.10.